Press releases | WebDisclosure

PRESS RELEASE

published on 01/23/2026 at 19:18, 7 months 21 days ago

JCDecaux : Shareholders of APG|SGA approve the selective opting up clause, paving the way for the sale of APG|SGA shares to NZZ
Shareholders of APG|SGA approve opting up clause, enabling sale of shares to NZZ. JCDecaux SE to sell 10.85% stake in APG|SGA. Transaction to complete in Q2 2026

Shareholders Sale Of Shares JCDecaux SE APG|SGA Opting Up Clause
PRESS RELEASE

published on 01/23/2026 at 19:18, 7 months 21 days ago

JCDecaux : Les actionnaires d'APG|SGA approuvent la clause d'« opting up » sélective, préalable à la cession de titres à NZZ
Les actionnaires d'APG|SGA approuvent la clause d'« opting up » sélective pour la cession de titres à NZZ, permettant à JCDecaux SE de finaliser la vente de 10,85% des actions. Transaction attendue au S2 2026

JCDecaux SE Cession De Titres APG|SGA Clause D'opting Up Autorités De La Concurrence
PRESS RELEASE

published on 01/23/2026 at 19:02, 7 months 21 days ago

Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program on the London Stock Exchange through Deutsche Bank AG, London Branch

London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Purchase Of Own Shares Deutsche Bank AG
PRESS RELEASE

published on 01/23/2026 at 19:00, 7 months 21 days ago

COMMUNIQUÉ DU 23 JANVIER 2026 RELATIF À LA MISE A DISPOSITION DU PUBLIC DE LA NOTE EN RÉPONSE ET DES INFORMATIONS RELATIVES AUX CARACTÉRISTIQUES, NOTAMMENT JURIDIQUES, FINANCIÈRES ET COMPTABLES DE SOCIETÉ DE TAYNINH
Communiqué du 23 janvier 2026 relatif à la mise à disposition du public de la note en réponse et des informations relatives aux caractéristiques, notamment juridiques, financières et comptables de Société de Tayninh dans le cadre de l'offre publique d'achat simplifiée

AMF Note En Réponse Offre Publique Communiqué Société De Tayninh
PRESS RELEASE

published on 01/23/2026 at 19:00, 7 months 21 days ago

Informations privilégiées / Autres communiqués
ABIONYX Pharma annonce son calendrier de communication financière pour l’exercice 2026, incluant les résultats annuels et semestriels ainsi que les positions de trésorerie

Communication Financière Biopharmaceutique ABIONYX Pharma Sepsis Calendrier 2026
PRESS RELEASE

published on 01/23/2026 at 19:00, 7 months 21 days ago

Inside Information / Other news releases
ABIONYX Pharma announces its financial calendar for 2026, including key events and dates for cash position updates and results releases

Financial Calendar ABIONYX Pharma Sepsis 2026 Therapeutic Era
PRESS RELEASE

published on 01/23/2026 at 18:50, 7 months 21 days ago

Mercedes-AMG PETRONAS F1 Team Announces Collaboration Agreement with Zuma
Azumi Ltd., owner of Zuma restaurants, collaborates with Mercedes-AMG PETRONAS F1 Team, shaping luxury hospitality in elite sport. Zuma becomes team's Lifestyle & Dining Curator

Hospitality Collaboration Agreement Mercedes-AMG PETRONAS F1 Team Zuma Azumi Ltd.
PRESS RELEASE

published on 01/23/2026 at 18:30, 7 months 21 days ago

SHOWROOMPRIVÉ PUBLISHES AN ADJUSTMENT TO ITS 2024 ANNUAL RESULTS AND ANNOUNCES ITS 2025 REVENUE
Showroomprivé publishes an adjustment to its 2024 annual results, reveals 2025 revenue details with a 14% decline, and announces Q4 2025 results. Board confirms its decision following a decline in business volume

Showroomprivé 2024 Annual Results 2025 Revenue Q4 2025 Financial Statement Adjustment
PRESS RELEASE

published on 01/23/2026 at 18:30, 7 months 21 days ago

SHOWROOMPRIVÉ PUBLIE UN AJUSTEMENT DE SES RÉSULTATS ANNUELS 2024 ET ANNONCE SON CHIFFRE D'AFFAIRES 2025
Showroomprivé publie un ajustement de ses résultats annuels 2024 et annonce son chiffre d'affaires 2025. Les résultats corrigent ceux du 13 mars 2025. Le CA 2025 en recul de -13,6%

Résultats Showroomprivé Volume D'affaires Ajustement CA 2025
PRESS RELEASE

published on 01/23/2026 at 18:05, 7 months 21 days ago

MASTRAD annonce la poursuite de son financement obligataire et une augmentation de capital.
MASTRAD annonce la poursuite du financement obligataire et une augmentation de capital pour renforcer sa situation financière. La société bénéficie d'une trésorerie temporaire et prévoit des investissements stratégiques

Augmentation De Capital Investissements Stratégiques Financement Obligataire Mastrad Trésorerie Temporaire

Published on 09/14/2026 at 15:15, 44 minutes ago

Mako Mining Announces a Non-Binding Letter of Intent to Enter a Gold Purchase Agreement with Sailfish Royalty to Lower its Cost of Capital and Facilitate Shareholder Returns and Accretive Acquisitions
Published on 09/14/2026 at 15:00, 59 minutes ago

Vox Royalty Completes Acquisitions of White Dam, Kalman and Sylvania Australian Gold & Copper Royalties
Published on 09/14/2026 at 14:30, 1 hour 29 minutes ago

Goldcliff Finalizes Drill Plans for New East Breccia Gold-Silver Target at Kettle Valley
Published on 09/14/2026 at 14:00, 1 hour 59 minutes ago

Revolve Completes Acquisition of 9.6 MW Operating Wind Project in the US
Published on 09/14/2026 at 14:00, 1 hour 59 minutes ago

Kinross Encounters Gold and Copper in Recent Drill Holes with Gold Values up to 6 g/t, Kinross Drilling to Continue on Dixie Halo

View all ACCESSWIRE

Published on 09/14/2026 at 15:26, 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/14/2026 at 15:25, 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 09/14/2026 at 15:25, 34 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 09/14/2026 at 15:23, 35 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Rotork plc
Published on 09/14/2026 at 15:23, 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS

Published on 09/11/2026 at 07:00, 3 days 8 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 days 8 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 3 days 8 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 days 8 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 3 days 20 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

News